Home
    DiscordDisclaimer

    Summary

    A nootropic drug of the racetam class, originally developed to treat Alzheimer's disease, it is currently being investigated as a treatment for major depressive disorder and generalised anxiety disorder. May be a modulator of the AMPA receptor. Limited recreational value.

    Dose Information

    Onset, Duration & After-effects

    • Onset:
      • Oral: 15-30 minutes
      • Insufflated: 1-5 minutes
      • Sublingual: 5-10 minutes
    • Duration:
      • 3-6 hours
    • After-effects:
      • 1-4 hours

    Helpful Links

    Known Combinations

    No interaction data available from Tripsit

    Studies & References